Theratechnologies to Seek Regulatory Approval of Trogarzo™ in Europe

Apr 24, 2018
PDF Version
Supporting Materials:

Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it will seek regulatory approval from the European Medicines Agency (EMA) for TrogarzoTM using efficacy and safety data from the clinical trials submitted to the U.S. Food and Drug Administration (FDA).